Microsoft Dynamics GP Trial
By: Microsoft View more from Microsoft >>
Download this next:
How streaming analytics offers business value
By: SAS
Type: White Paper
Many analytics and BI tools limit your ability to get insight in time to make a critical business decision. Once you detect a pattern, you have to work with a data scientist to choose data sets for more analysis, clean the data of noise, and code a query, all while the data becomes less and less relevant with passing time.
This resource explains streaming analytics and describes how it can enable real-time decision-making based on current evidence. Learn how you can resolve business problems more quickly and make data-driven decisions.
These are also closely related to: "Microsoft Dynamics GP Trial"
-
Expert guide: Streaming analytics FAQ
By: SAS
Type: eGuide
The growing number of connected devices is increasing the volume of data about business activity. Companies that capture and analyze this data with streaming analytics to find problems before they impact the customer experience have a competitive advantage over companies that don’t.
This expert e-guide provides answers to frequently asked questions about streaming analytics, including:
- Why “streaming analytics?” Isn’t traditional analytics enough?
- Is streaming analytics right for my business?
- And more
-
Predictive analytics: Empower business users
By: SAS
Type: White Paper
In order to make critical decisions, business users need access to analytics tools that they can understand in order to gain insight into everyday problems and help prevent failures in the future.
This resource discusses how interactive data discovery and predictive analytics technologies can empower business users to make smarter, data-driven business decisions faster. Learn how to:
- Identify new trends and relationships in historical data sets
- Quickly share results with colleagues
- And more
Find more content like what you just read:
-
Five Must-Have Capabilities to Boost Data Intelligence Value
By: Quest
Type: White Paper
Discover five must-have data intelligence capabilities to boost business value, including accelerating data product delivery, leveraging data modeling to advance governance, and integrating data quality automation. Learn how to maximize the value of your data and analytics pipelines by reading this white paper.
-
ESG: The evolving state of data intelligence and AI governance
By: Quest
Type: ESG Research Report
In this research report from TechTarget’s Enterprise Strategy Group, you’ll gain the latest insights into data intelligence challenges, strategies, and impacts and find out how you can ensure data quality and data readiness to support AI use. Read on now to learn more about the critical roles of data intelligence and AI governance.
-
How data democratization will transform industries
By: DataBricks
Type: Research Content
In this new report from MIT Tech Review Insights, 600 CIOs and senior tech executives from the world’s most innovative companies share their journeys to data intelligence. Read on now to learn the strategies — as well as the struggles — of top leaders at Walmart, Morgan Stanley, AT&T and more.
-
Unify Data Management: Enterprise Strategy Group Report
By: Google Cloud
Type: ESG Economic Validation Report
As data and data sources proliferate, organizations are striving to eliminate complexity and unify their data-management strategies. One way they can do so, this Economic Validation Report by Enterprise Strategy Group explores, is by leveraging Google Cloud Dataflow. Read on to discover the cost savings that this approach can drive.
-
Improve Business Outcomes with Decision Intelligence
By: InterSystems
Type: Product Overview
By leveraging the Supply Chain Orchestrator, supply chain businesses can recognize, understand, optimize, and leverage data more efficiently to create an agile and resilient supply chain model. Read on to learn how you can utilize the tool to improve productivity and drive value for your business.
-
Designing a comprehensive intent data strategy
By: Informa TechTarget
Type: eBook
Teams relying only on traditional inward-focused insight sources are at a widening disadvantage as B2B buyer preference for self-directed solution research has already begun reducing the chances today’s vendor teams have to break through. Designing a comprehensive intent data strategy can help you avoid challenges. Learn how in this e-book.
-
What does GenAI in action look like for life sciences?
By: AWS Marketplace
Type: eBook
In the Powering the New Era of Life Sciences Innovations eBook, explore how Life Sciences leaders are using GenAI to unlock new possibilities and transform the Life Sciences industry. From accelerating drug discovery to delivering differentiated therapeutics to market, learn how technologies from AWS for Life Sciences are driving innovation.
-
Empowering Clinical Research in a Distributed World
By:
Type: Video
Many Contract Research Organizations (CROs) and Sponsors are applying technology to enhance clinical trials, resulting in improvements like faster and more representative trial enrollment, and better participant experiences. Since COVID-19, particular attention is being paid to ‘decentralized’ clinical trials (DCT) and hybrid clinical trials. Effective modernization of trials requires understanding of clinical research and supporting technologies. Supporting the shift to DCT and hybrid trials also places significant demand on data management, infrastructure, and its integration to facilitate increasingly complex trial design, analytics and enhancement needs. In this session, Khondoker Huq and Jeff Kenkel will discuss: - What organizations are doing to capture the full value of their clinical research data – wherever the data is generated - Benefits of Decentralized and Hybrid Clinical Trials - Challenges facing adoption of DCT and Hybrid Trials - Organizations supporting DCT standards and advancements - Complexity of technology solutions with IoT analytics - Intelligent technologies that allow for data collection from ‘edge-to-core’ and communication out to trial participants and other trusted third parties
-
Women are underrepresented in medical device clinical trials
By: XtelligentMedia Healthcare
Type: eGuide
A research letter published in JAMA Internal Medicine found that medical device clinical trials had a median female participant rate of 33%.
-
The Power of Global Standardization: Unlock High Quality Flow Cytometry Results
By:
Type: Talk
Flow Cytometry can interrogate multiparametric measurements on individual cells and has become a widely used specialty testing platform for clinical trials. In addition to the importance of evaluating single-cell analysis throughout the drug development lifecycle, there are increasingly new flow cytometry instruments being introduced that can enhance the researcher’s ability to produce high-quality patient results. One of the challenges that exist when conducting a global clinical trial is the ability to standardize laboratory flow cytometers across sites while also producing rigorous and comparable results in either an exploratory or critical endpoint analysis. Attend this webinar to learn: • Important considerations when designing and validating cytometry panels for use across multiple sites and instruments. • Understanding aspects of flow cytometry assessments in either a regulatory or non-regulatory setting. • Validation of a high-complexity Immuno-Oncology panel to interrogate human patient samples as part of a global clinical trial.
-
Diversity in Clinical Trials : A more inclusive approach in patient recruitment
By:
Type: Talk
We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient recruitment. Between 2008 and 2018, fewer than two in three (63%) of the 230 clinical trials that led to cancer drug approvals by the Food and Drug Administration (FDA) in the US, recorded participants’ ethnicity. This lack of diversity is a major issue: studies show that different groups can respond to treatments in various ways, resulting in some medicines being prescribed differently. This session will highlight some of the factors underpinning the lack of patient diversity in clinical trials, investigate the implications this has for patients, and discuss what we can do in practice to improve diversity in clinical trials. Speakers Kate Shaw - Founder/CEO - Innovative Trials Sandra Amro - Global Clinical Trial Diversity Team Lead- Pfizer Jane Thurston - Senior Patient Recruitment Lead - Parexel Learning Objective What are the factors behind the lack of representations in clinical trials? What are the consequences of the lack of diversity in Clinical Trials? How do we improve diversity in clinical trials in practice?
-
Voices to Trials: Engaging Patients in Clinical Trial Design
By:
Type: Talk
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to methods for incorporating patient voice in the development of new therapeutics, specifically as part of clinical trials.
-
Leveraging AI and RWE for Emerging Biopharma Forecasting
By: SAS + Intel + Circulant
Type: Presentation Transcript
Emerging biopharma companies are leveraging AI and real-world evidence (RWE) to enhance forecasting and decision-making. By integrating these technologies, they can predict clinical outcomes, market trends, and patient needs more accurately. Download this e-book to learn how AI and RWE are transforming biopharma forecasting.
-
Clinical Trials: How effective patient engagement shapes key decision making
By:
Type: Talk
Join us on 20th May, which marks Clinical Trials Day, as we ask – how can we better understand the patient experience for better clinical trial outcomes? In our upcoming webinar, we are delighted to be joined by Mark Doyle, Founder, A Life in a Day and Emma Sutcliffe, VP, Head Global Patient Affairs, Ipsen, discuss the transformative journey of clinical trials and the pivotal role patient-centric approaches play in enhancing outcomes. Join us as Emma shares her insights, shedding light on how a patient-centric focus has become integral to the development and deployment of clinical trials at Ipsen. Delve into practical strategies employed by Emma and her team at Ipsen, supported by immersive learning strategies explored by Mark, to place patients at the forefront of their trials, ultimately elevating the quality and effectiveness of the research. We will also be diving into the outcomes of employing these strategies, with both speakers sharing insights into the outcomes achievable by better understanding the patient experience and using empathy to drive better outcomes in trials. Participate in this on-demand webinar to: • Foster collaboration with patients for enhanced trial outcomes. • Gain firsthand insights into effectively understanding and addressing patient challenges within trials. • Explore innovative approaches to design and execute trials with a heightened focus on patient needs.
-
How can synthetic control arms & real-world data redefine clinical trial design?
By:
Type: Talk
Synthetic Control Arms (SCAs) have the potential to reduce the number of trial participants, eliminate delays, and lower costs. In this webinar experts from the worlds of clinical trials and clinical AI will present and discuss the factors to consider when planning to use an SCA as part of a clinical trial.
-
Tips and Tricks to Get the Most Out of Your Pentaho Trial
By:
Type: Video
Want to learn more about the Pentaho Trial? Then attend this recorded webcast that focuses on big data and data integration best practices as well as how to get the most out of your Pentaho 30-day trial. Other topics include: * A review the components that are part of your trial and best approach to get started *A discussion on the best way to connect to your data and manage your analytical pipeline * A showcase our library of videos, tutorials and documentation for a smooth trial * Highlights of proven best practices to make the most of your 30-day download
-
Pilot and Trial: the 2nd Stage of Implementing Quantum Networks
By:
Type: Talk
There are 3 key stages to launching a Quantum Network: Design and Emulation, Pilot and Trial, and Full Scale Deployment. In this session Matthew Skrzypczyk, Software Engineer at Aliro Quantum, will walk you step by step through the Pilot and Trial stage. Business leaders and technologists will gain a comprehensive understanding of the second stage to implementing Quantum Networking, including: – How to know you’re ready to move from the Design and Emulation stage to the Pilot and Trial stage – The requirements for building a Quantum Network pilot – The benefits of that can be leveraged at this stage – Pitfalls to avoid as you build your pilot quantum network – How to know when you’re ready to move from the Pilot and Trial stage to the Full Scale Deployment stage The next technology revolution will be quantum - and quantum networks are essential to the transformation. Organizations who are on the cutting edge of disrupting and transforming their industries are investigating how to pilot and launch Quantum Networks. This webinar will prepare you for navigating the quantum future.
-
[DIA Europe 2024] ACT EU and the Future of Clinical Research in Europe
By:
Type: Video
The session will focus on the Accelerating clinical trials in the EU (ACT EU) initiative, which aims to transform clinical trials in the European Union. The keynote speech will outline the European Medicines Regulatory Network’s vision for clinical research in the region, reflecting on the progress towards better, faster and optimised clinical trials and highlighting key milestones under ACT EU. A panel of stakeholder representatives will exchange views on the main challenges and opportunities for improving the clinical trial environment in Europe.
-
Navigating patients step by step on their clinical trial journey
By:
Type: Talk
For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in extra financial costs for sponsors and potentially placing the future of the trial in jeopardy. However, sites don’t always have the time and resources available to commit to ongoing and consistent patient engagement. In our upcoming webinar, we will discuss common challenges participants and sites face when it comes to engagement and how our new ‘Navigator’ service is helping to change the game. Hear how our new patient-centric service benefits patients, sites and sponsors by ensuring patients get the support they need for the best clinical trial experience possible decreasing the risk of early trial termination by improving the retention of participants until the very end of a study reducing the burden on sites by performing a second layer of pre-screening, allowing sites to focus on the science. Speakers: Chair - John Pinching, Editor at PharmaTimes Kari Reilly - Patient Recruitment Manager, Innovative Trials Kristin Faber - VP of Clinical Trial Patient Recruitment, Spectrum Science Adel Sepulveda - Patient Navigator, Innovative Trials TBC - Site
-
The evolution of clinical research: embracing new delivery models in the UK
By:
Type: Talk
Clinical trial delivery in the UK is evolving to take trial activities to the patients, delivering research in different ways, such as remote, decentralised, virtual or hybrid trials. Join the NIHR for the chance to learn from real-life examples as panellists explore how they overcame practical challenges to establish this model and highlight opportunities to achieve more accessible research for participants and real-world evidence.
-
Solving your biggest patient recruitment and retention challenges
By:
Type: Talk
*To ensure this webinar caters to your specific interests, we would greatly appreciate it if you could spare just 2 minutes to complete a brief survey after registering. Your input matters to us: https://www.surveymonkey.co.uk/r/DFWLXGM Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to enrolment issues [1,2], and poor recruitment is a common reason for discontinuation [3]. Of those successfully enrolled, around 30% are likely to drop out [4], which increases costs for sponsors and threatens the viability of the trial itself. Directly supporting patients from prescreening to study endpoint can help minimize delays and safeguard against early termination, but this can be difficult for hard-pressed sites. Join us as we discuss the most common patient support challenges – as described to us by YOU – and how our new Navigator service can solve them by giving patients a more personalized clinical trial experience and consistent contact, alleviating the burden on sites, and ensuring a sponsor’s study runs efficiently to help accelerate patient access to life-changing treatments. We will share our insight into why the ‘human touch’ can elevate your in-study patient engagement to the next level and how this permeates through our Navigator service to benefit patients, sites and sponsors. You will also hear from a sponsor that has benefitted from our expertise: the difficulties they faced, the solutions we implemented and the difference we made. And we will share feedback from clinical trial participants about what they think of our support. Speakers Chair John Pinching, Editor, PharmaTimes Laura Burt Director of Operations, Innovative Trials Kari Reilly Site Operations Lead, Innovative Trials Helen Andrews Global Clinical Trial Manager, Avillion Amy Lopez Navigator, Innovative Trials
-
Complex Innovative Design Trials
By:
Type: Video
Complex innovative design trials are revolutionizing clinical research by adopting new and advanced methodologies beyond the standard randomized controlled trial design, resulting in accelerated drug development and improved patient outcomes. In this session, regulators and industry experts discuss the development of master protocol studies, acceptance of the design and data of these trials by key-decision makers, as well as the impact of IMI EU-PEARL’s deliverables.
-
Sentinel LDK – Trial Unlocked Licenses
By:
Type: Video
In questo video è dimostrata la creazione, l’installazione ed il consumo di licenze SL Trial per abilitare la valutazione di un software modulare.
-
Accelerating patient recruitment in clinical trials post COVID-19
By:
Type: Talk
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market. But recruitment is also one of the biggest challenges for trials. More than four in five studies fail to meet their recruitment deadlines, which can result in costly delays for sponsors and puts sites under increasing pressure. This issue has been exacerbated by the COVID-19 pandemic; with many trials initially put on hold and now restarting, sponsors want to make up for lost time by accelerating patient recruitment and retention. However, clinical trial staff are struggling to clear this enrollment backlog. This webinar will explore some of the key challenges to patient recruitment particularly since COVID-19, and highlight how a 'boots on the ground' approach via Clinical Enrollment Managers (CEMs) can help supercharge patient recruitment and retention strategy by: understanding the local environment and culture in each country where sites are based working with sites and developing strategies to help them overcome recruitment barriers sustained community engagement within key patient populations, including those who are traditionally underrepresented in trials Learning Objective - COVID19 and Patient Recruitment Challenges - Accelerating patient recruitment with local CEMs - Benefits of deploying a boots-on-the-ground approach Who Should attend Pharma, Clinical Research Organisations (CROs) and Biotech senior leadership Clinical Trial/Clinical Study Leads Clinical Operations Specialists Clinical Operations Directors/VPs Therapeutic Strategy Leads
-
Patient Recruitment: Think Global, Act Local
By:
Type: Talk
Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust data - but also promotes health equity and research and innovation across continents. Another benefit of global clinical trials is the potential for these studies to be completed more quickly and efficiently [1]. However, around four in five clinical trials fail to meet their patient recruitment deadlines [2], which delays patient access to innovative new therapeutics and can prove costly to Sponsors. Just as treatments are becoming more personalized, so should clinical trial patient recruitment strategies. A ‘one size fits all’ approach to enrollment fails to consider how factors such as an individual country’s culture, healthcare structure and patients’ needs can affect a site’s ability to recruit eligible participants. The key to patient enrollment success is to ‘think local’, even for global studies. In this webinar, we will: Discuss the benefits of using a diversified patient recruitment approach for each country within a global study Investigate how patient recruitment strategies can differ from country to country, Hear from two in-country patient recruitment specialists about the challenges relevant to their regions and how they work with sites to overcome these Share how Innovative Trials’ ‘boots-on-the-ground’ approach in more than 70 countries around the world can help accelerate patient recruitment and retention for your clinical trials. Speakers: Georgia Harding - Patient Recruitment Manager, Innovative Trials - georgia.hardy@innovativetrials.co.uk Nicole Yingst - Strategist, Pfizer - Nicole.Yingst@pfizer.com Barbara OrlosKaminska- Clinica Enrolment Manager (Poland), Innovative Trials - barbara.orloskaminska@innovativetrials.co.uk Speaker 4: TBC
-
Augmented analytics tools: a complete guide
By: TechTarget ComputerWeekly.com
Type: eGuide
Augmented analytics tools are designed to simplify the BI and analytics process for business users and citizen data scientists. They've become featured elements in new software releases from BI vendors. This e-guide offers insights into the technology's potential uses and critical issues.
-
Data integration to support modern BI and advanced analytics programmes
By: TechTarget ComputerWeekly.com
Type: eGuide
In this e-guide we discuss why data integration and preparation are the unsung heroes of modern BI and advanced analytics. More so than ever, it would seem, due to the ever-increasing volume and variety of data.
-
Advanced analytics meld with machine learning to press more value from big data
By: TechTarget ComputerWeekly.com
Type: eGuide
In this e-guide we shine the light on a number of case studies taken from around the world of data analytics. We delve into a number of Silicon Valley-based startups that are looking to shake up the data analytics industry as well as glimpsing into the future of AI-based analytics, data visualisation tools and the Australian data analytics market.
-
Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape
By:
Type: Talk
In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to pose significant obstacles. As we navigate through the complexities of the current year, experts in the field—namely, Kate Shaw, Leanne Whoehlke, and Will Krugman—will delve into pivotal aspects of patient recruitment and retention challenges. The discussion will intricately explore strategies to augment awareness of clinical trials within the broader public sphere, contemplating innovative approaches to engage with local communities. The focus remains steadfast on ensuring that patient recruitment and retention remain robust throughout the clinical trials course. This discourse promises to illuminate and address critical issues, propelling the clinical trial industry toward enhanced efficacy and patient-centred success. Kate Shaw - Founder & CEO, Innovative Trials Leanne Woehlke - Director, Life Sciences Solutions, TransPerfect Will Krugman - Marketing & Communications Director, Clinical Research Associates
-
FIH Trial Trends: How far we've come and where we're going with PK data
By:
Type: Video
Discover an informative webinar delving into pharmacokinetics (PK) in first-in-human (FIH) studies and how it optimizes the data points in clinical trials. In the ever-evolving landscape of pharmaceutical research, it’s crucial to keep a close eye on the changes in PK in FIH trials over the past decade. These changes hold valuable insights that can significantly impact the success of clinical studies. The influence of PK data on clinical study decision-making cannot be overstated; it serves as a cornerstone in shaping the direction of drug development. Furthermore, comprehending how PK data gathered in FIH trials can be leveraged to optimize data collection in long-term patient studies is paramount. It also enables researchers to streamline the data points collected, enhancing efficiency and reducing the burden on patients while ensuring that the clinical trial remains robust and informative.
-
Navigating Complex & Adaptive Oncology Trials: Key Challenges & Solutions
By:
Type: Replay
Compared to traditional oncology trials, complex and adaptive trial designs require more flexibility, precision, and innovation in their execution. In this webinar, clinical development experts will provide an in-depth look into strategic approaches and innovative solutions necessary for navigating these oncology trials. They will offer insights, practical solutions, and progressive strategies to tackle significant issues in regulatory compliance, statistical methodologies, and data management. Topics include: -Strategies for navigating regulatory hurdles -Project Optimus & key FDA projects and programs -Considerations for BOIN & Bayesian designs -Cohort complexity management
-
Business Analytics: how AI is augmenting analysis, and bolstering data literacy shortfalls
By: TechTarget ComputerWeekly.com
Type: eGuide
Artificial Intelligence and human analysis have been coming together in recent years. Whether using packaged BI and data preparation tools, or languages like Python and R, business analysts and data scientists and engineers alike have been exploring the use of machine learning algorithms to augment their data analyses. Read more in this e-guide.
-
Uniting Communities for Rare Disease Clinical Trial Success
By:
Type: Talk
Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into the multifaceted landscape of patient engagement, recruitment, and retention challenges and solutions, with a particular focus on the rare disease DADA2. Explore how the synergy between community engagement, trust-building, and interconnected networks among physicians and patients holds the key to unlocking the full potential of clinical trials. Discover actionable insights and transformative strategies that can redefine the trajectory of clinical trial success in rare diseases. Speakers Kate Shaw - Founder & CEO, Innovative Trials Leanne Woehlke - Director, Life Sciences Solutions, TransPerfect Will Krugman - Marketing & Communications Director, Clinical Research Associates Chip Chambers - Founder & President, DADA2 Foundation
-
Patient Perspectives to Improve Retention with eConsent
By:
Type: Replay
With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹. One of the biggest drivers in keeping patients enrolled is the consent process. Traditional informed consent forms are frequently cited as confusing, leaving patients unsure of what their trial will require of them². In order to improve the process, we must meet patients on their own terms and find new ways to educate and engage them. At Medable, we use our Patient Advisory Council (PAC) to review our own clinical trial technology and best practices, helping ensure patients leave the consent process truly informed. Join Medable and key PAC members as we discuss common challenges faced by patients looking to participate in clinical trials. We will explore how a patient-first approach to informed consent can improve patient education, engagement, and comprehension, ultimately improving retention. Attendees will learn about: 1. The challenges of understanding consent information 2. Ideas on how to design the ICF and patient consent process to be patient-centric 3. Considerations in offering the choice of in-person or remote consent 4. Best practices in incorporating technology to increase engagement and comprehension *Sources: ¹Applied Clinical Trials. Can Recruitment and Retention Get Any Worse? Dec 2019. Ken Getz ²Advarra. Retention in Clinical Trials: Keeping Patients on Protocols. Mar 2021.
-
Driving Culture Change: Phorest's Observability Transformation
By: Honeycomb
Type: Blog
Phorest, a global salon software company, chose Honeycomb to foster observability and reduce debugging time. Honeycomb's affordable pricing and support enabled adoption, empowering engineers to understand their system and make data-driven decisions. Read the full case study to learn how Phorest improved their customer experience with Honeycomb.
-
Pioneering GenAI for Product Development at Vodafone
By: Atlassian
Type: Case Study
In 2024, three organizations – Vodafone, Accenture and Atlassian – embarked on the first trial of Atlassian Intelligence and Rovo. Watch this webcast to find out how Vodafone used the generative AI technology to improve its product development lifecycle.
-
CW APAC - February 2022: Trend Watch - enterprise 5G
By: TechTarget ComputerWeekly.com
Type: Ezine
In this handbook, focused on enterprise 5G in the Asia-Pacific region, Computer Weekly looks at what the technology means for enterprises across the region.
-
Collaboration software in the era of Gen-Z
By: TechTarget ComputerWeekly.com
Type: eGuide
In this e-guide, learn how Microsoft is dominating the Software-as-a-Service space thanks to its strength in collaboration software and how the new generation of collaboration software could be stoking communication overload. Also, check out our chart comparing Slack, Microsoft Teams and Spark.
-
Beyond clinical: Boosting recruitment and retention with SDOH data
By:
Type: Talk
The success of clinical trials depends on various factors beyond traditional clinical care, including social determinants of health (SDOH) like housing, health literacy, transportation, and social support. These factors can impact participant recruitment, retention, and the quality of data collected. In this webinar, panelists will explore how industry leaders are using non-clinical data to improve recruitment, retention, and evidence generation in clinical trials.
-
AI: Beyond the hype
By: TechTarget ComputerWeekly.com
Type: eGuide
Artificial Intelligence is red hot. But what lies beyond the hype? Once it was big data, then cloud, now it is artificial intelligence, and that sub-set of it which is machine learning, that's generating more heat than light. Is there business value here?
-
Computer Weekly 22 January 2019: Moving beyond network boundaries
By: TechTarget ComputerWeekly.com
Type: Ezine
In this week's Computer Weekly, we look at how businesses are adapting to the challenges of perimeterless network security. We examine how digital transformation is bringing increased complications for identity and access management. And we ask if public cloud providers are a threat to the funding model for open source software. Read the issue now.
-
Accelerating Software Development with Gen AI: Gemini Code Assist
By:
Type: Video
Are you ready to revolutionize your software development lifecycle (SDLC)? Watch this session and discover how Gemini Code Assist, your next-generation AI-powered collaborator, can revolutionize your development process. You'll learn: - How Gemini's AI capabilities accelerate development workflows. - Real-world examples of how development teams are leveraging Gemini for success. - How to get started with your own free trial of Gemini Code Assist.
-
Top 5 Factors for Choosing a Key Management Solution
By: Utimaco
Type: BrightTALK Webinar
Navigating Key Management can be complex, especially when selecting a new vendor. This webcast covers the top 5 considerations to choose the ideal solution for your business. Learn best practices and get insights into Utimaco's offerings. Watch the full BrightTALK webinar now to learn more and make an informed decision.
-
EU Clinical Trial Regulation
By:
Type: Video
EU Clinical Trial Regulation: Balancing Requirements Related To Transparency And To Protection Of Personal Private Data And Commercially Confidential Data The session aims to cover an overview of the different requirements on transparency, the data protection regulation for personal private data, and the set-up for how commercially confidential data might be protected. The focus will be on the strategic view of achieving transparency and the utility of data in CTIS while ensuring EU remains attractive for clinical trials by ensuring sponsors commercially confidential information is protected.
-
Artificial Intelligence and Machine Learning in data analytics and business applications
By: TechTarget ComputerWeekly.com
Type: eGuide
Artificial Intelligence and the sub-set of it which is machine learning are hot. It's been impossible to attend an IT conference in the last year or so without encountering a dead human genius reincarnated as a software system or a robot.
-
Computer Weekly – 5 June 2018: The bumpy ride to digital transformation
By: TechTarget ComputerWeekly.com
Type: Ezine
In this week's Computer Weekly, we look at the lessons to be learned from General Electric's bumpy ride to digital transformation. We assess the use of software-defined networking in corporate IT infrastructures. And we find out how Royal Bank of Scotland approaches digital and business innovation. Read the issue now.
-
See How it’s Done: Case Studies on Patient Experience Design
By:
Type: Video
In this webinar, you’ll hear from experts dedicated to creating accessible studies that capture the data sponsors need to move to the next stage in product development. Hear from clinical development professionals who have worked with sponsors across therapeutic areas, phases, and modalities to dig into the details of their protocols, examine their application, and ultimately design trials that work for diverse patients. They’ll be joined by a patient advocate who recently collected extensive patient and researcher community data that will be used to inform clinical development for GLUT1 deficiency syndrome. Together, they’ll dive into real-world examples from their work that you can apply to your program, showing how to de-risk your protocol and truly design your trial with the patient in mind. In this webinar, you’ll learn how to: Design trials with a patient experience approach Consider data that is important to patient communities Examine a protocol for patient experience optimization Apply real-life examples to your study
-
Receptor Occupancy Assays: A Comprehensive Guide for Clinical Trial Success
By:
Type: Talk
Join Champions Oncology for an exclusive live webinar focused on the pivotal role of Receptor Occupancy (RO) assays in clinical trials. Key Learning Objectives: • Deep-Dive into RO Assay Types: Gain a detailed understanding of the different types of RO assays available and learn to select the one that perfectly aligns with your clinical project needs. • Critical Development Considerations: Uncover the essential considerations that guide the development of a robust RO assay and ensure reliability in a clinical setting. • Flow Cytometry Validation Mastery: Equip yourself with the necessary skills to validate RO assays for flow cytometry with confidence, enhancing the accuracy and impact of your clinical trials. By attending this webinar, you're not just accessing information; you're joining a community of expert scientists determined to make a mark in the fight against cancer. Whether you're aiming to refine an existing assay in-house or planning future assays for upcoming clinical trials, this comprehensive guide to RO assays is an indispensable asset.
-
Software Monetization Matters: The Art of Software Packaging
By:
Type: Replay
Software entitlements provide software providers and software-driven hardware companies the ability to control who is using what features, where they are using them (specific devices), and for how long. The beauty of a robust and flexible software entitlement program is the ability to utilize this control to customize offerings for your end user. Perhaps your prospective customer cannot commit to a perpetual license agreement. You could offer a monthly subscription. What if they want to try out a new feature before committing to purchasing? Entitlements allow you to offer a free trial period. Explore the many creative packaging possibilities with Thales software monetization experts Adrian Pearce and Rachel Present Schreter in this 20 minute webchat.
-
A Computer Weekly buyer's guide to Business Intelligence and Analytics
By: TechTarget ComputerWeekly.com
Type: eGuide
Business intelligence and analytics is an ever-changing landscape. In this 20-page buyer's guide, Computer Weekly looks at firms' search for data scientists, how modern business intelligence works for big data and the role DevOps can play in navigating a data onslaught.
-
Overcoming Patient Recruitment Challenges in Rare Disease Trials
By:
Type: Talk
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments. We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market. With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will: explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trials hear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials. Learning Objective Patient recruitment challenges in rare disease studies Challenges in sickle cells studies Family/Patient perspective Accelerating patient recruitment in rare disease studies Speaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative Trials Speaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease) Speaker 3 - Margaret Alege - Patient
-
How AI is supercharging clinical trials
By:
Type: Talk
Experts in clinical trial technology, design and execution will come together in a moderated discussion to explore these different facets of the opportunities created by AI, both traditional and generative.
-
Improbotics: AI Creativity with an Artist-In-The-Loop
By:
Type: Video
Piotr Mirowski, founder of Improbotics, explains how this revolutionary improv theatre project aims at demystifying how AI works (from speech recognition to chatbots) and how it embraces learning by trial and error.
-
Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations
By:
Type: Video
After bringing groundbreaking treatment advancements to oncology, CAR T therapies are beginning to show promise in additional therapeutic areas. As these advanced therapies enter clinical trials in new patient communities, successful programs rely on understanding which elements of the oncology construct can be seamlessly applied in the new paradigm. In this webinar, panelists will discuss how the collaboration between therapeutically aligned teams impacts study delivery for CAR T in autoimmune disease and neurology clinics. Discussions will include considerations for sponsor, site, and patient stakeholders. Don’t miss this chance to learn from the successful implementation of CAR T trials and to ask the panelists your own questions
-
Edwin Coe - The Litigation Process - Stage 3 'Going to Trial'
By:
Type: Talk
In the final webinar Edwin Coe will focus on the run up to trial, dealing with witnesses and witness statements, identifying and utilising experts, the trial process and giving evidence, appeals and enforcement of judgments. NOTE: This webinar has been made available by the Chartered Institute of Loss Adjusters (CILA) solely for the use and convenience of the viewer. The content, views and representations made in this presentation are the sole product and responsibility of the speakers who have produced it. By making this presentation available the CILA does not offer any endorsement or recommendation of the views and opinions expressed therein. For a full explanation of the terms and conditions upon which the CILA provides this webinar please see our full disclaimer which available on the Institute website.
-
Embracing Innovation to Modernize Clinical Trial Analytics
By: Domino
Type: Webcast
In this webcast, you’ll discover how GSK was able to upgrade from their legacy environment to support employees and accelerate the drug development process. Tune in now to discover lessons learned in their transformation journey and find out how embracing flexibility and innovation can help you modernize clinical trial analytics and reporting.